MeetKai announced the rollout of its sovereign AI platform across six countries—Brazil, Ukraine, Pakistan, Kazakhstan, Uzbekistan, and Bangladesh—serving over 700 million people. The platform, built entirely on NVIDIA accelerated computing, enables each country to run AI models locally without relying on foreign cloud services, ensuring data sovereignty. Key projects include a national-scale AI factory in Ukraine with Kyivstar and a public tender win in Brazil with SERPRO. This initiative supports local AI skill development and secure, air-gapped AI deployments for governments and enterprises. Expansion plans also include markets in Africa, leveraging NVIDIA technology.
MeetKai's sovereign AI platform expansion across six countries provides context for readers interested in technology developments. For readers following the Technology sector, here is Pluang's market snapshot as of Sep 25, 2026 19:02 WIB: out of 150 priced US tech stocks, 107 rose and 35 fell. Among notable movers, AXTI rose 3.23% to USD 78.35 with a typical hold time of 16 days, KD increased 3.07% to USD 12.10 with a 36-day hold time, and FSLY gained 2.62% to USD 27.38 with a 26-day hold time and a buy order activity of 62%.
Assured Guaranty Ltd. (NYSE: AGO) saw its stock price pressured to a new 52-week low of $68.04 despite a recent upgrade to "Buy" by Roth Capital. The company is involved in the financial restructuring of Brightline Florida, where a subsidiary insured...
Legacy Education Inc. reported Q4 2026 earnings with an EPS of $0.13, missing analyst estimates of $0.15, and revenue of $20.1 million, slightly below expectations. Despite this, the company achieved a 12% year-over-year revenue increase in Q4 and a ...
Carnival Corporation & plc is set to report Q3 earnings with analysts forecasting $8.39 billion in revenue and $1.36 EPS, reflecting a 4.9% decline from last year. The company's stock has dropped 27% recently due to a 30% surge in Brent oil prices, w...
Oklo, a pre-revenue nuclear tech company, is developing advanced small modular reactors (SMRs) called Aurora Powerhouses aimed at clean energy for data centers. UBS set a price target of $41, indicating a 7.08% upside from the current $38.29 stock pr...
Barclays initiated coverage on Ligand Pharmaceuticals with an 'Overweight' rating and set a price target of $345, implying a 15.37% upside from its current price. The biopharma company is expanding its royalty portfolio through investments in cancer ...
